CFG
EW icon

Citizens Financial Group’s Edwards Lifesciences EW Stock Holding History

Citizens Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Sell
4,810
-67
-1% -$5.52K 0.01% 609
2025
Q4 		$416K Buy
4,877
+365
+8% +$30K 0.01% 588
2025
Q3 		$351K Buy
4,512
+630
+16% +$49.2K ﹤0.01% 607
2025
Q2 		$304K Buy
3,882
+949
+32% +$70.8K ﹤0.01% 572
2025
Q1 		$213K Buy
+2,933
New +$210K ﹤0.01% 577
2023
Q3 		– Sell
-2,706
Closed -$255K – 359
2023
Q2 		$255K Sell
2,706
-3,150
-54% -$274K 0.01% 343
2023
Q1 		$484K Sell
5,856
-557
-9% -$43.8K 0.02% 292
2022
Q4 		$478K Sell
6,413
-2,196
-26% -$169K 0.02% 271
2022
Q3 		$711K Sell
8,609
-4,055
-32% -$390K 0.03% 223
2022
Q2 		$1.2M Sell
12,664
-539
-4% -$55.8K 0.05% 178
2022
Q1 		$1.55M Buy
13,203
+1,357
+11% +$152K 0.05% 167
2021
Q4 		$1.53M Sell
11,846
-681
-5% -$79.4K 0.05% 178
2021
Q3 		$1.42M Buy
12,527
+8,219
+191% +$938K 0.05% 178
2021
Q2 		$446K Sell
4,308
-4,902
-53% -$462K 0.02% 250
2021
Q1 		$770K Sell
9,210
-123,263
-93% -$10.4M 0.04% 173
2020
Q4 		$12.1M Sell
132,473
-2,385
-2% -$198K 0.69% 40
2020
Q3 		$10.8M Buy
134,858
+2,284
+2% +$178K 0.69% 42
2020
Q2 		$9.16M Sell
132,574
-2,612
-2% -$186K 0.64% 46
2020
Q1 		$8.5M Sell
135,186
-8,097
-6% -$584K 0.69% 43
2019
Q4 		$11.1M Sell
143,283
-7,437
-5% -$581K 0.74% 40
2019
Q3 		$11M Sell
150,720
-2,601
-2% -$183K 0.8% 40
2019
Q2 		$9.44M Sell
153,321
-4,812
-3% -$291K 0.69% 49
2019
Q1 		$10.1M Buy
158,133
+5,721
+4% +$326K 0.74% 45
2018
Q4 		$7.78M Sell
152,412
-1,665
-1% -$84.2K 0.71% 54
2018
Q3 		$8.94M Sell
154,077
-1,041
-0.7% -$50.9K 0.71% 52
2018
Q2 		$7.53M Sell
155,118
-4,023
-3% -$188K 0.63% 57
2018
Q1 		$7.4M Buy
+159,141
New +$6.91M 0.62% 59

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Citizens Financial Group's EW Position: Q1 2026 in Review

Citizens Financial Group reduced its Edwards Lifesciences (EW) stake by 1.4% in Q1 2026, selling an estimated $5.52K and leaving 4,810 shares worth $385K. The position accounts for 0.01% of the portfolio, ranked #609.

Citizens Financial Group first reported a position in EW in Q1 2018 and has held it in 27 quarters since. The position peaked at $12.1M in Q4 2020. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Citizens Financial Group held 4,810 shares of Edwards Lifesciences worth $385K as of Q1 2026.
  • Citizens Financial Group sold 67 Edwards Lifesciences shares in Q1 2026, an estimated $5.52K.
  • Edwards Lifesciences made up 0.01% of Citizens Financial Group's portfolio in Q1 2026, its #609 holding.
  • Citizens Financial Group first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 27 quarters since.
  • Citizens Financial Group's Edwards Lifesciences position peaked at $12.1M in Q4 2020.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.